Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.

Jalila Chagraoui1, Sherry L Niessen, Julie Lessard

  • 1Laboratory of Molecular Genetics of Hematopoietic Stem Cells, Institut de Recherche en Immunologie et Cancérologie (IRIC), CP 6128 succursale Centre-Ville, Montréal, Québec, Canada.

Genes & Development
|August 3, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

Bone marrow transplantation·2026
Same author

<i>TP53</i>-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

Science advances·2026
Same author

TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells.

Life science alliance·2026
Same author

The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer.

Oncogene·2026
Same author

A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.

bioRxiv : the preprint server for biology·2026
Same author

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Open forum infectious diseases·2026

Researchers identified E4F1 as a novel partner of the Polycomb gene Bmi1 in hematopoietic cells. Reducing E4F1 levels rescues Bmi1-deficient stem cell function, revealing E4F1 as a key regulator of Bmi1 activity.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Epigenetics

Background:

  • The Polycomb group gene Bmi1 is crucial for neural and hematopoietic stem cell proliferation.
  • The severe hematopoietic phenotype in Bmi1 mutant mice is only partially rescued by loss of p53 or p16(Ink4a)/p19(Arf).

Purpose of the Study:

  • To identify novel BMI1-interacting partners in hematopoietic cells.
  • To elucidate the role of E4F1 in regulating Bmi1-dependent hematopoietic stem cell proliferation.

Main Methods:

  • Co-immunoprecipitation to identify BMI1-interacting proteins.
  • Genetic interaction studies in hematopoietic stem cells.
  • RNA interference (RNAi) mediated knockdown of E4F1.
  • Colony-forming unit (CFU) assays and long-term repopulating ability assessments post-transplantation.

Related Experiment Videos

Main Results:

  • E4F1 was identified as a novel BMI1-interacting partner in hematopoietic cells.
  • Bmi1 and E4F1 exhibit genetic interaction in regulating hematopoietic cell proliferation.
  • Knockdown of E4F1 rescued the clonogenic and repopulating capacity of Bmi1(-/-) hematopoietic stem cells.
  • The functional interaction between Bmi1 and E4F1 is independent of p53 and the INK4A/ARF pathway.

Conclusions:

  • E4F1 is a key modulator of BMI1 activity in primitive hematopoietic cells.
  • Targeting E4F1 represents a potential therapeutic strategy for Bmi1-related hematopoietic disorders.